Form 8.3 - [Allergan plc ]
March 18 2020 - 10:43AM
Dow Jones News
TIDM0Y7T TIDM0QCV
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING
1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) State Street Global Advisors &
Affiliates
--------------------------------------------- -------------------------------
Company dealt in Allergan plc
--------------------------------------------- -------------------------------
Class of relevant security to which US$0.0001 ordinary shares
the dealings being disclosed relate (Note 2)
--------------------------------------------- -------------------------------
Date of dealing 17(th) March 2020
--------------------------------------------- -------------------------------
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of
relevant security dealt in (Note 3)
Long Short
------------------------------------- -------------------- -----------
Number (%) Number (%)
------------------------------------- ---------- -------- ------ ---
(1) Relevant securities 13,649,963 4.14675%
------------------------------------- ---------- -------- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------- ---------- -------- ------ ---
(3) Options and agreements to
purchase/sell N/A
------------------------------------- ---------- -------- ------ ---
Total 13,649,963 4.14675%
------------------------------------- ---------- -------- ------ ---
(b) Interests and short positions in relevant securities of the company,
other than the class dealt in (Note 3)
Class of relevant security: Long Short
------------------------------------------- ----------- -----------
Number (%) Number (%)
------------------------------------------- ------ --- ------ ---
(1) Relevant securities N/A
------------------------------------------- ------ --- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------------- ------ --- ------ ---
(3) Options and agreements to purchase/sell N/A
------------------------------------------- ------ --- ------ ---
Total N/A
------------------------------------------- ------ --- ------ ---
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit (Note 5)
-------------- ----------------------------- -----------------------
Purchase 2,500 171.84
-------------- ----------------------------- -----------------------
Purchase 180 171.84
-------------- ----------------------------- -----------------------
Purchase 800 171.84
-------------- ----------------------------- -----------------------
Purchase 200 171.84
-------------- ----------------------------- -----------------------
Purchase 1,630 159.62
-------------- ----------------------------- -----------------------
Purchase 5,713 171.84
-------------- ----------------------------- -----------------------
Purchase 1,772 171.84
-------------- ----------------------------- -----------------------
Purchase 50 171.84
-------------- ----------------------------- -----------------------
Purchase 3,845 159.62
-------------- ----------------------------- -----------------------
Purchase 2,187 159.62
-------------- ----------------------------- -----------------------
Purchase 3,245 159.62
-------------- ----------------------------- -----------------------
Purchase 100 171.84
-------------- ----------------------------- -----------------------
Purchase 45 171.84
-------------- ----------------------------- -----------------------
Purchase 352 168.54
-------------- ----------------------------- -----------------------
Purchase 65 171.84
-------------- ----------------------------- -----------------------
Purchase 360 171.84
-------------- ----------------------------- -----------------------
Purchase 1,368 171.84
-------------- ----------------------------- -----------------------
Sale 100 171.84
-------------- ----------------------------- -----------------------
Sale 600 171.84
-------------- ----------------------------- -----------------------
Sale 800 171.84
-------------- ----------------------------- -----------------------
Sale 100 171.84
-------------- ----------------------------- -----------------------
Sale 200 171.84
-------------- ----------------------------- -----------------------
Sale 2,500 171.84
-------------- ----------------------------- -----------------------
Sale 132 171.84
-------------- ----------------------------- -----------------------
Sale 107,562 171.84
-------------- ----------------------------- -----------------------
Sale 1,840 171.84
-------------- ----------------------------- -----------------------
Sale 484 171.84
-------------- ----------------------------- -----------------------
Sale 161 171.84
-------------- ----------------------------- -----------------------
Sale 60 171.84
-------------- ----------------------------- -----------------------
Sale 126 171.84
-------------- ----------------------------- -----------------------
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
------------- --------------------- ----------------------------- --------------
N/A
------------- --------------------- ----------------------------- --------------
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, Number of Exercise Type, e.g. Expiry Option money
e.g. call option purchasing securities to which price American, date paid/received
varying etc. the option relates European etc. per unit (Note 5)
(Note 7)
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
N/A
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
(ii) Exercising
Product name, Number of securities Exercise price per
e.g. call option unit (Note 5)
----------------- -------------------- ------------------
N/A
----------------- -------------------- ------------------
(d) Other dealings (including transactions in respect of new securities)
(Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
--------------------- ------- -------------------------
N/A
--------------------- ------- -------------------------
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or
derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person
relating to the voting rights of any relevant securities
under any option referred to on this form or relating
to the voting rights or future acquisition or disposal
of any relevant securities to which any derivative
referred to on this form is referenced. If none, this
should be stated.
-----------------------------------------------------------
N/A
-----------------------------------------------------------
Is a Supplemental Form 8 attached? (Note 9) NO
------------------------------------------------------- -----------------
Date of disclosure 18(th) March 2020
------------------------------------------------------- -----------------
Contact name Lionel Colaco
------------------------------------------------------- -----------------
Telephone number 020 33956098
------------------------------------------------------- -----------------
If a connected EFM, name of offeree/offeror with which N/A
connected
------------------------------------------------------- -----------------
If a connected EFM, state nature of connection (Note N/A
10)
------------------------------------------------------- -----------------
(END) Dow Jones Newswires
March 18, 2020 10:28 ET (14:28 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Mar 2024 to Apr 2024
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Apr 2023 to Apr 2024
